查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1806306

胜肽合成市場（按產品類型、技術、應用和最終用戶分類）—全球預測，2025-2030 年

Peptide Synthesis Market by Product Type, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年胜肽合成市場價值為 7.0096 億美元，預計到 2025 年將成長至 7.5389 億美元，複合年成長率為 7.84%，到 2030 年將達到 11.031 億美元。

主要市場統計數據
基準年2024年 7.096億美元
預計2025年 7.5389億美元
預測年份 2030 11.031億美元
複合年成長率（%） 7.84%

為下一代胜肽合成奠定基礎的全面、前瞻性的介紹

肽合成已成為現代生物技術的基石，推動了治療、診斷和研究應用領域的突破。化學合成和酶促合成技術的進步使得肽序列能夠以前所未有的速度和保真度進行精確組裝，從而推動了學術實驗室、受託研究機構和製藥公司的創新。當今肽合成領域的特點是整合了自動化平台、高通量工作流程和先進的純化系統，所有這些都旨在滿足藥物開發平臺和分析實驗室的嚴格要求。

確定將重新定義胜肽合成並推進現代行業標準的創新技術和市場變化

胜肽合成領域正在經歷變革時期，自動化合成平台的快速發展使研究人員能夠以驚人的精度生產複雜的胜肽鏈。高通量合成儀如今融合了模組化設計和即時監控功能，縮短了循環時間並提高了可重複性。這些創新與先進的純化系統相輔相成，該系統利用高效液相層析法和先進樹脂，能夠提供符合治療藥物開發嚴格標準的高純度胜肽。

揭示2025年美國關稅調整對胜肽合成供應鏈與產業動態的累積影響

2025年，美國關稅政策的調整將對胜肽合成供應鏈產生累積影響，尤其對從主要製造地進口的層析法設備、冷凍乾燥機和關鍵試劑產生影響。關稅再平衡增加了某些零件的到岸成本，迫使各機構重新評估籌資策略。許多實驗室正在採取多種應對措施，包括擴大供應商組合，探索其他區域夥伴關係關係，並加快國內設備供應商的資格認證流程，以降低關稅波動的風險。

重點細分洞察，突出肽合成在產品類型、技術、應用和最終用戶方面的不同方面

胜肽合成市場涵蓋多種產品類型，包括設備、試劑和耗材以及服務等關鍵類別。設備包括純化所必需的層析法設備、用於溫和乾燥胜肽的先進凍乾機，以及支援自動偶聯和去保護循環的尖端合成機。試劑和耗材涵蓋了從氨基酸和專用耦合試劑到用於螢光標記的染料和高性能樹脂等各種構建模組和載體，它們在序列保真度和下游分析中都發揮著至關重要的作用。為了補充這些特定產品，服務供應商提供分析測試、客製化胜肽生產和方法開發方面的專業知識，以確保無縫整合到合成工作流程中。

深入探討主要區域觀點，重點在於美洲、歐洲、中東和非洲以及亞太地區的趨勢和成長動力

胜肽合成的區域動態揭示了美洲、歐洲、中東和非洲以及亞太地區的獨特優勢和新興機會。在美洲，北美是創新的中心樞紐，這得益於強大的學術合作和高度集中的醫藥研發舉措。拉丁美洲則由於對本地契約製造的投資以及對生物製藥開發的關注而逐漸擴張。

確定推動胜肽合成領域創新和領導地位的主要企業的競爭格局和策略概況

胜肽合成的競爭格局由儀器製造商、試劑供應商和專業服務機構組成。領先的儀器供應商不斷透過模組化設計、雲端監控和人工智慧主導的流程控制來增強其合成平台，以滿足多樣化的研究和生產需求。領先的試劑供應商正在透過高純度胺基酸、胜肽合成試劑套件和創新偶聯化學技術來擴展其產品組合，同時透過生物基溶劑和可回收樹脂優先考慮永續性。

使相關人員能夠應對複雜的情況並利用新的機會，透過可行的建議改變產業的發展軌跡

致力於掌握胜肽合成複雜性的行業領導者應優先投資自動化數位化技術，以提高產量並最大限度地減少人為錯誤。與新興技術供應商建立策略聯盟可以提供專業的合成平台和新型化學方法，而合作研究夥伴關係則可以加速治療和診斷應用領域的創新。同時，企業應透過多元化供應商關係、從多個地區採購關鍵試劑以及整合先進的物流解決方案來提高供應鏈的敏捷性，從而實現彈性採購。

嚴謹的調查方法和分析框架的詳細資訊，有助於深入了解胜肽合成的多方面領域

本分析綜合了嚴謹的調查方法，結合了一手資料和二手資料，得出了深刻的見解。一手資料研究包括對來自學術機構、合約組織和生物製藥公司的思想領袖、合成科學家和採購專家的深入訪談。二手資料研究則廣泛查閱了同行評審日誌、專利資料庫、監管備案文件、技術規格和企業資料，以檢驗新興趨勢和技術進步。

結論和策略考量為胜肽合成的演變和未來方向提供了視角

總而言之，肽合成產業的特點是技術快速發展、監管格局不斷變化以及競爭格局瞬息萬變。自動化、混合合成平台和數位分析技術的進步正在提高效率，並為肽基治療和診斷技術開闢新的可能性。創新生態系統和供應鏈韌性的地區差異凸顯了策略在地化和跨境合作的重要性。同時，關稅協調和永續性要求正在重塑籌資策略和流程最佳化的優先事項。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 在胜肽合成中實施綠色化學方法，以最大限度地減少環境影響和廢棄物產生
  • 胜肽環化和裝訂技術在改善代謝穩定性和細胞滲透性的進展
  • 採用自動化固相胜肽合成平台可提高產量並減少批次差異
  • 引入微流體實驗室晶片系統，用於按需合成胜肽並加速藥物研發週期
  • 擴大客製化胜肽的合約開發和製造夥伴關係，以滿足特殊的治療需求
  • 將人工智慧驅動的胜肽設計演算法與高通量合成工作流程結合
  • 引入連續流反應器，實現可擴展的胜肽 API 生產和即時製程最佳化
  • 透過使用非標準氨基酸和胜肽模擬物開發具有增強生物活性的下一代療法

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章胜肽合成市場（依產品類型）

  • 裝置
    • 層析法設備
    • 冷凍乾燥設備
    • 胜肽合成儀
  • 試劑和耗材
    • 胺基酸
    • 耦合試劑
    • 染料和螢光標記試劑
    • 樹脂
  • 服務

第9章 胜肽合成市場（按技術）

  • 混合技術
  • 液相胜肽合成
  • 固相胜肽合成

第 10 章 胜肽合成市場（依應用）

  • 化妝品
  • 診斷
  • 研究與開發
  • 治療

第 11 章。按最終用戶分類的胜肽合成市場

  • 學術研究
  • 臨床實驗室
  • CRO
  • 製藥和生物技術公司

12. 美國胜肽合成市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 歐洲、中東和非洲胜肽合成市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

14. 亞太肽合成市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • 2B Scientific Limited
    • AAPPTec LLC
    • ABclonal, Inc.
    • Advanced ChemTech by Thorn BioScience LLC
    • Almac Group Limited
    • AmbioPharm Inc.
    • AnaSpec Inc.
    • Bachem AG
    • Biocon Limited
    • BioDuro LLC
    • Biosynth Ltd.
    • Biotage AB
    • CEM Corporation
    • CPC Scientific Inc.
    • Creative Diagnostics
    • Creative Peptides
    • CSBio Sciences Private Limited
    • Enamine Ltd.
    • GenScript Biotech Corporation
    • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
    • JPT Peptide Technologies GmbH by TheraCode GmbH
    • Kaneka Corporation
    • LifeTein LLC
    • Merck KGaA
    • New England BioGroup, LLC
    • Novo Nordisk A/S
    • PolyPeptide Group AG
    • Thermo Fisher Scientific Inc.
    • USV Private Limited

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-431388EE3B9B

The Peptide Synthesis Market was valued at USD 700.96 million in 2024 and is projected to grow to USD 753.89 million in 2025, with a CAGR of 7.84%, reaching USD 1,103.10 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 700.96 million
Estimated Year [2025] USD 753.89 million
Forecast Year [2030] USD 1,103.10 million
CAGR (%) 7.84%

Establishing the Foundation for Next-Generation Peptide Synthesis Through a Comprehensive and Forward-Looking Introduction

Peptide synthesis has emerged as a cornerstone of modern biotechnology, driving breakthroughs in therapeutics, diagnostics, and research applications. Advances in chemical and enzymatic synthesis techniques have enabled precise assembly of peptide sequences with unprecedented speed and fidelity, fueling innovation across academic laboratories, contract research organizations, and pharmaceutical companies. Today's peptide synthesis landscape is marked by the integration of automation platforms, high-throughput workflows, and advanced purification systems, all designed to meet the rigorous demands of drug development pipelines and analytical laboratories.

Against this backdrop, the industry is witnessing a convergence of multidisciplinary insights spanning synthetic chemistry, biophysics, and data science. The marriage of machine learning algorithms with peptide design tools is accelerating the discovery of novel bioactive molecules while enhancing process optimization and cost efficiency. Moreover, the growing emphasis on sustainable practices has catalyzed the adoption of green chemistry principles in reagent selection and waste reduction, aligning with broader environmental and regulatory imperatives.

As peptide therapeutics continue to gain traction in areas such as oncology, infectious disease, and metabolic disorders, stakeholders across the value chain are pursuing strategic partnerships to expand capabilities, secure supply chains, and navigate complex regulatory landscapes. Increasing collaboration between instrument manufacturers, reagent suppliers, and service providers is reshaping the ecosystem, fostering innovation hubs and specialized contract facilities dedicated to peptide production. Collectively, these developments underscore the dynamic evolution of peptide synthesis and set the stage for the deeper exploration of technological, economic, and regional factors that follow in this report.

Identifying Transformative Technological and Market Shifts Redefining Peptide Synthesis and Elevating Industry Standards in the Modern Era

The peptide synthesis sector is undergoing transformative shifts driven by rapid advancements in automated synthesis platforms, enabling researchers to produce complex peptide chains with remarkable precision. High-throughput synthesizers now incorporate modular designs and real-time monitoring features, reducing cycle times and enhancing reproducibility. These innovations are complemented by sophisticated purification systems that leverage high-performance liquid chromatography and advanced resins to deliver peptides with exceptional purity, meeting the stringent standards required for therapeutic development.

Equally impactful is the rise of hybrid technologies that blend solid-phase and liquid-phase approaches, providing unparalleled flexibility for synthesizing a diverse range of peptides, including long sequences and modified analogs. Such hybrid systems streamline workflows by integrating coupling, deprotection, and cleavage steps into seamless processes. This convergence of methodologies is further amplified by digitalization initiatives, where laboratory information management systems and AI-driven analytics facilitate predictive maintenance, yield optimization, and adaptive synthesis protocols based on historical performance data.

Regulatory landscapes are evolving in parallel, with agencies worldwide refining guidelines for peptide therapeutics and associated manufacturing practices. This regulatory clarity is fostering greater confidence among stakeholders and catalyzing investment in large-scale peptide production facilities. As a result, the competitive dynamics of the peptide synthesis market are shifting, with established players and new entrants alike racing to differentiate through specialized offerings, strategic alliances, and value-added services that cater to emerging therapeutic targets and diagnostic applications.

Unpacking the Cumulative Impact of United States Tariff Adjustments in 2025 on Peptide Synthesis Supply Chains and Industry Dynamics

In 2025, adjustments to United States tariff policies have exerted a cumulative impact on the peptide synthesis supply chain, particularly affecting imports of chromatography instruments, lyophilizers, and critical reagents from key manufacturing hubs. The rebalancing of duties has led to increased landed costs for certain components, prompting organizations to reassess sourcing strategies. Many laboratories have responded by diversifying supplier portfolios, seeking alternative regional partnerships, and accelerating qualification processes for domestic equipment vendors to mitigate exposure to tariff fluctuations.

At the same time, reagent manufacturers and consumable suppliers have faced pressure to absorb or offset tariff-related cost increases, leading some to renegotiate contracts and introduce value-engineered reagent lines. Service providers in contract research and manufacturing have also adapted their pricing models, incorporating surcharges and longer lead times to account for supply chain uncertainties. While these adjustments have introduced complexity into procurement cycles, they have concurrently spurred the development of resilient sourcing frameworks and closer collaboration between end users and suppliers to maintain continuity of operations in peptide synthesis workflows.

Gleaning Key Segmentation Insights to Illuminate Diverse Dimensions of Peptide Synthesis Spanning Products Technologies Applications and End Users

The peptide synthesis market encompasses a diverse array of product types, with core categories including equipment, reagents & consumables, and services. Equipment spans chromatography instruments essential for purification, advanced lyophilizers for gentle drying of peptides, and state-of-the-art synthesizers that support automation of coupling and deprotection cycles. Reagents and consumables cover the full spectrum of building blocks and supports, from amino acids and specialized coupling reagents to dyes for fluorescent labeling and high-performance resins, each playing a critical role in sequence fidelity and downstream analysis. Complementing these tangible offerings, service providers deliver analytical testing, custom peptide production, and method development expertise, ensuring seamless integration of synthesis workflows.

Technological segmentation further highlights distinctions among hybrid platforms that blend solid-phase and liquid-phase chemistries, dedicated liquid-phase peptide synthesis systems for long-chain peptides, and solid-phase instruments optimized for rapid cycle synthesis of shorter sequences. Each technology pathway addresses specific application requirements, balancing throughput, peptide length capacity, and customization flexibility.

Applications of peptide synthesis extend across cosmetics, where bioactive peptides rejuvenate skin and hair treatments; diagnostic assays that leverage labeled peptides for biomarker detection; research and development efforts in drug discovery; and therapeutic modalities that harness peptide-based drugs for targeted treatment. End users range from academic research institutions pioneering novel peptide designs to clinical laboratories conducting biomarker validation, from contract research organizations offering turnkey peptide synthesis services to pharmaceutical and biotechnology companies advancing peptide therapeutics from concept to clinic. This multi-dimensional segmentation underscores the nuanced requirements and value drivers tailored to each segment of the peptide synthesis ecosystem.

Delving into Key Regional Perspectives Uncovering Trends and Growth Drivers Across Americas Europe Middle East Africa and the Asia Pacific

Regional dynamics within peptide synthesis reveal unique strengths and emerging opportunities across the Americas, Europe, Middle East & Africa, and Asia-Pacific domains. In the Americas, North America serves as a central hub for innovation, bolstered by robust academic collaborations and a high concentration of pharmaceutical R&D initiatives. Latin America is witnessing gradual expansion, driven by investments in local contract manufacturing and a growing emphasis on biopharmaceutical development.

Europe maintains leadership in regulatory harmonization and quality standards, with Western Europe at the forefront of advanced research intensification. The Middle East & Africa region is experiencing early-stage growth, supported by government initiatives to enhance biotechnology capabilities and develop local manufacturing capacities. Meanwhile, Asia-Pacific stands out as a dynamic frontier, where countries such as China, India, Japan, and South Korea are scaling up peptide synthesis infrastructure, driven by cost-effective manufacturing, government research budgets, and a burgeoning base of biotech startups.

Across these regions, collaborative networks are strengthening, with cross-border partnerships enabling technology transfer, capacity expansion, and shared expertise. This regional interplay shapes procurement strategies, influences regulatory compliance pathways, and redefines competitive positioning for global and local players in the peptide synthesis arena.

Unlocking Key Company Competitor Landscapes and Strategic Profiles That Drive Innovation and Leadership within the Peptide Synthesis Sector

The competitive landscape in peptide synthesis features a blend of instrumentation manufacturers, reagent suppliers, and specialized service organizations. Leading instrument vendors are continuously enhancing synthesis platforms with modular designs, cloud-enabled monitoring, and AI-driven process controls to meet diverse research and production needs. Key reagent suppliers are expanding their portfolios with high-purity amino acids, peptide synthesis kits, and innovative coupling chemistries, while prioritizing sustainability through bio-based solvents and recyclable resins.

Specialized service providers have carved out strategic niches by offering end-to-end peptide manufacturing, from custom sequence design to bulk production and analytical support. Contract research organizations are strengthening their capabilities with dedicated pilot-scale facilities and rigorous quality management systems to expedite the transition of peptide leads into clinical development. Across the board, strategic partnerships, licensing agreements, and targeted acquisitions are enabling companies to broaden their reach, integrate complementary technologies, and accelerate time to market. These concerted efforts reflect the intense drive toward differentiation through value-added services, regulatory expertise, and robust supply chain resilience in the global peptide synthesis sector.

Transforming Industry Trajectories with Actionable Recommendations Empowering Stakeholders to Navigate Complexities and Capitalize on Emerging Opportunities

Industry leaders seeking to navigate the complexities of peptide synthesis should prioritize investments in automation and digitalization to boost throughput and minimize human error. Establishing strategic alliances with emerging technology providers can unlock access to specialized synthesis platforms and novel chemistries, while collaborative research partnerships can accelerate innovation across therapeutic and diagnostic applications. Concurrently, companies should enhance supply chain agility by diversifying vendor relationships, sourcing critical reagents from multiple geographies, and integrating advanced logistics solutions for resilient procurement.

Sustainability initiatives must be embedded throughout peptide production workflows, including adoption of green solvents, recycling programs for consumables, and continuous process optimization to reduce energy consumption. Strengthening capabilities in regulatory intelligence will ensure timely alignment with evolving guidelines, expediting approval pathways and market entry. Finally, talent development strategies that focus on interdisciplinary skill sets-spanning synthetic chemistry, analytical science, and data analytics-will position organizations to harness technological innovation and capitalize on emerging opportunities within the peptide synthesis ecosystem.

Detailing Rigorous Research Methodology and Analytical Frameworks Underpinning Insights in the Multifaceted Domain of Peptide Synthesis

This analysis integrates insights derived from a rigorous research methodology that combines primary and secondary data sources. Primary research involved in-depth interviews with thought leaders, synthesis scientists, and procurement specialists across academic institutions, contract organizations, and biopharma companies. Secondary research encompassed a thorough review of peer-reviewed journals, patent databases, regulatory filings, technical specifications, and corporate disclosures to validate emerging trends and technological advancements.

Analytical frameworks underpinning this study include SWOT assessments to evaluate internal strengths and external threats, PESTLE analysis to contextualize macro-environmental factors, and Porter's Five Forces to gauge competitive intensity. Market segmentation mapping provided granular visibility into product categories, technology platforms, applications, and end-user perspectives. Quality assurance measures such as data triangulation, cross-verification of sources, and expert peer reviews ensured the credibility and reliability of findings. This structured approach delivers a comprehensive and nuanced understanding of the peptide synthesis landscape.

Concluding Reflections and Strategic Considerations Providing a Cohesive Outlook on the Evolution and Future Direction of Peptide Synthesis

In conclusion, the peptide synthesis sector is characterized by rapid technological evolution, shifting regulatory frameworks, and dynamic competitive landscapes. Advances in automation, hybrid synthesis platforms, and digital analytics are driving efficiency and unlocking new possibilities for peptide-based therapeutics and diagnostics. Regional variations in innovation ecosystems and supply chain resilience underscore the importance of strategic localization and cross-border collaboration. Meanwhile, tariff adjustments and sustainability imperatives are reshaping procurement strategies and process optimization priorities.

By synthesizing segmentation insights with company profiles and actionable recommendations, this analysis equips decision-makers with a holistic view of the landscape. Staying attuned to emerging trends, investing in advanced technologies, and fostering agile, sustainable operations will be critical for organizations aiming to maintain leadership in the peptide synthesis arena. The insights presented herein offer a clear roadmap for navigating current challenges and capitalizing on the transformative potential of peptide science.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Implementation of green chemistry approaches in peptide synthesis to minimize environmental impact and waste generation
  • 5.2. Advancements in peptide cyclization and stapling techniques to improve metabolic stability and cell permeability
  • 5.3. Adoption of automated solid-phase peptide synthesis platforms to enhance throughput and reduce batch variability
  • 5.4. Deployment of microfluidic lab-on-a-chip systems for on-demand peptide synthesis and accelerated drug discovery cycles
  • 5.5. Expansion of custom peptide contract development and manufacturing partnerships to meet specialized therapeutic demands
  • 5.6. Integration of artificial intelligence-driven peptide design algorithms with high-throughput synthesis workflows
  • 5.7. Emergence of continuous flow reactors for scalable peptide API production and real-time process optimization
  • 5.8. Use of noncanonical amino acids and peptidomimetics to create next-generation therapeutics with enhanced bioactivity

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Peptide Synthesis Market, by Product Type

  • 8.1. Introduction
  • 8.2. Equipment
    • 8.2.1. Chromatography Equipment
    • 8.2.2. Lyophilizers
    • 8.2.3. Peptide Synthesizers
  • 8.3. Reagents & Consumables
    • 8.3.1. Amino Acids
    • 8.3.2. Coupling Reagents
    • 8.3.3. Dyes & Fluroscent Labeling Reagents
    • 8.3.4. Resins
  • 8.4. Services

9. Peptide Synthesis Market, by Technology

  • 9.1. Introduction
  • 9.2. Hybrid Technology
  • 9.3. Liquid Phase Peptide Synthesis
  • 9.4. Solid Phase Peptide Synthesis

10. Peptide Synthesis Market, by Application

  • 10.1. Introduction
  • 10.2. Cosmetics
  • 10.3. Diagnosis
  • 10.4. Research & Development
  • 10.5. Therapeutics

11. Peptide Synthesis Market, by End-User

  • 11.1. Introduction
  • 11.2. Academic Research
  • 11.3. Clinical Laboratories
  • 11.4. Contract Research Organizations
  • 11.5. Pharmaceutical & Biotech Companies

12. Americas Peptide Synthesis Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Peptide Synthesis Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Peptide Synthesis Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. 2B Scientific Limited
    • 15.3.2. AAPPTec LLC
    • 15.3.3. ABclonal, Inc.
    • 15.3.4. Advanced ChemTech by Thorn BioScience LLC
    • 15.3.5. Almac Group Limited
    • 15.3.6. AmbioPharm Inc.
    • 15.3.7. AnaSpec Inc.
    • 15.3.8. Bachem AG
    • 15.3.9. Biocon Limited
    • 15.3.10. BioDuro LLC
    • 15.3.11. Biosynth Ltd.
    • 15.3.12. Biotage AB
    • 15.3.13. CEM Corporation
    • 15.3.14. CPC Scientific Inc.
    • 15.3.15. Creative Diagnostics
    • 15.3.16. Creative Peptides
    • 15.3.17. CSBio Sciences Private Limited
    • 15.3.18. Enamine Ltd.
    • 15.3.19. GenScript Biotech Corporation
    • 15.3.20. Gyros Protein Technologies AB by Mesa Laboratories, Inc.
    • 15.3.21. JPT Peptide Technologies GmbH by TheraCode GmbH
    • 15.3.22. Kaneka Corporation
    • 15.3.23. LifeTein LLC
    • 15.3.24. Merck KGaA
    • 15.3.25. New England BioGroup, LLC
    • 15.3.26. Novo Nordisk A/S
    • 15.3.27. PolyPeptide Group AG
    • 15.3.28. Thermo Fisher Scientific Inc.
    • 15.3.29. USV Private Limited

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. PEPTIDE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. PEPTIDE SYNTHESIS MARKET: RESEARCHAI
  • FIGURE 24. PEPTIDE SYNTHESIS MARKET: RESEARCHSTATISTICS
  • FIGURE 25. PEPTIDE SYNTHESIS MARKET: RESEARCHCONTACTS
  • FIGURE 26. PEPTIDE SYNTHESIS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. PEPTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUPLING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUPLING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DYES & FLUROSCENT LABELING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DYES & FLUROSCENT LABELING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESINS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COSMETICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 101. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 102. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 103. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 113. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 114. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 115. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 118. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 121. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 122. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 123. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 126. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 127. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 130. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 131. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 132. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 133. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 134. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 135. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 137. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 138. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 165. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 168. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 169. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 170. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 171. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 173. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 175. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 176. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 177. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 180. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 181. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 182. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 183. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 185. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 187. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 188. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 189. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 192. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 193. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 194. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 195. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 197. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 200. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 201. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 204. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 205. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 206. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 207. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 209. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 211. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 212. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 213. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 217. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 218. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 219. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 221. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 224. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 240. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 242. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 248. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 252. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 254. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 259. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 260. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 261. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 264. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 265. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 266. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 267. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 269. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 272. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 276. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 278. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 281. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 283. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 284. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 285. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 288. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 289. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 290. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 291. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 293. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 295. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 296. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 297. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 300. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 301. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 302. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 303. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 304. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 305. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 307. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 308. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 309. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 311. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 312. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 313. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 314. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 315. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 317. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 319. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 320. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 321. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 323. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 324. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 325. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 326. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 327. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 328. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 329. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 331. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 332. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 333. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 335. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 336. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 337. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 338. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 339. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 340. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 341. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 343. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 344. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 345. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 347. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 348. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 349. TURKEY PEPTIDE